December 2010 Heart Health

Cycloset (quick-release formulation of bromocriptine mesylate), a dopamine D2 agonist, is a novel agent recently approved by the FDA for type 2 diabetes mellitus.

Lauren Simonds helps undeserved populations whose health care needs are often overlooked.

The pharmacy profession is on the cusp of major changes, but individual pharmacists must be willing to step up to the plate.

A veteran investigator reflects on his 2 decades of experience working with pharmacies to handle drug diversion and abuse cases.

A patient who experienced a rare side effect sued the pharmacy that dispensed the drug on the grounds that a pharmacist failed to warm her.

Are all products labeled "natural" safe and do they really improve symptoms? Pharmacists can answer these and other questions patients have about herbal supplements.

Arming patients with essential knowledge about pulmonary arterial hypertension empowers them to make informed decisions about their health.

Nominations for the 2011 Next-Generation Pharmacists Awards will be open soon as we celebrate the winners in 2010.

Groundbreaking studies on the diagnosis, treatment, and prevention of stroke and heart disease were presented at the American Heart Association's scientific meeting in November.

Delaying CPR can drastically reduce a patient;s chances of surviving a medical emergency. Knowing the American Heart Association's new guidelines ensures a quick and effective response.

Pradaxa (dabigatran etexilate) is the first oral direct thrombin inhibitor to be approved by the FDA.

Patients taking dabigatran etexilate should be closely monitored for altered responses to this newly approved oral anticoagulant.

Drugs with similar names are a threat to patient safety, and pharmacists must be on high alert when filling and dispensing these medications.